A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014)

Ziemssen Tjalf; Bajenaru Ovidiu A.; Carra Adriana; de Klippel Nina; de Sa Joao Correia; Edland Astrid; Frederiksen Jette L.; Heinzlef Olivier; Karageorgiou Klimentini E.; Delgado Rafael H. Lander; Landtblom Anne-Marie; Macias Islas Miguel A.; Tubridy Niall; Gilgun-Sherki Yossi

首页> 外文期刊>Journal of neurology >A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014)

【24h】

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014)

机译：一项为期2年的观察性研究，针对复发缓解型多发性硬化症患者通过其他疾病缓解疗法转化为醋酸格拉替雷：COPTIMIZE试验（第261卷，第2101页，2014年）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of neurology》 |2015年第1期|共1页
作者
Ziemssen Tjalf; Bajenaru Ovidiu A.; Carra Adriana; de Klippel Nina; de Sa Joao Correia; Edland Astrid; Frederiksen Jette L.; Heinzlef Olivier; Karageorgiou Klimentini E.; Delgado Rafael H. Lander; Landtblom Anne-Marie; Macias Islas Miguel A.; Tubridy Niall; Gilgun-Sherki Yossi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学;
关键词

相似文献

外文文献
中文文献
专利

1. A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014) [J] . Ziemssen Tjalf, Bajenaru Ovidiu A., Carra Adriana, Journal of neurology . 2015,第1期

机译：一项为期2年的观察性研究，针对复发缓解型多发性硬化症患者通过其他疾病缓解疗法转化为醋酸格拉替雷：COPTIMIZE试验（第261卷，第2101页，2014年）
2. Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing–remitting multiple sclerosis converting to glatiramer acetate [J] . Tjalf Ziemssen, Yossi Gilgun-Sherki BMC Neurology . 2015,第1期

机译：对复发缓解型多发性硬化症转化为醋酸格拉替雷的患者进行为期2年的观察性COPTIMIZE试验的地域差异分项分析
3. Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing–remitting multiple sclerosis converting to glatiramer acetate [J] . Tjalf Ziemssen, Yossi Gilgun-Sherki BMC Neurology . 2015,第1期

机译：对复发缓解型多发性硬化症转化为醋酸格拉替雷的患者进行为期2年的观察性COPTIMIZE试验的地域差异分项分析
4. Comparison of Changes in the Number of Included Patients Between Interventional Trials and Observational Studies Published from 1995 to 2014 in Three Leading Journals [C] . Arnaud DEZETREE, Emmanuel CHAZARD, Daniel R. SCHLEGEL, EFMI STC 2018 . 2018

机译：介入试验与观察研究之间包括患者数量的变化比较从1995年到2014年在三个领先的期刊中发布
5. Aging and Disease-modifying Therapies in Multiple Sclerosis: Insights from Clinical Trials and Registries [D] . Zhang, Yinan. 2021

机译：多发性硬化症中的衰老和疾病改性疗法：临床试验和注册管理机构的见解
6. A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial [O] . Tjalf Ziemssen, Ovidiu A. Bajenaru, Adriana Carrá, -1

机译：一项为期2年的观察性研究针对患有复发缓解型多发性硬化症的患者从其他疾病缓解疗法转变为醋酸格拉替雷：COPTIMIZE试验
7. A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial [O] . Ziemssen, Tjalf, Bajenaru, Ovidiu A., Carra, Adriana, 2014

机译：一项为期2年的观察性研究，针对患有复发缓解型多发性硬化症的患者从其他疾病缓解疗法转变为醋酸格拉替雷：COPTIMIZE试验

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial (vol 261, pg 2101, 2014)

著录项

相似文献

相关主题

期刊订阅